Matthew E Li Kam Wa, Kalpa De Silva, Nilesh Pareek, Divaka Perera
{"title":"冠状动脉血管重建与院外心脏骤停:过去、现在和未来。","authors":"Matthew E Li Kam Wa, Kalpa De Silva, Nilesh Pareek, Divaka Perera","doi":"10.17925/HI.2021.15.2.94","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiologists and the cardiac catheter laboratory have key roles to play in the management of patients after out-of-hospital cardiac arrest (OHCA). Although immediate catheter laboratory activation is the standard of care in cardiogenic shock and ST elevation myocardial infarction, the majority of patients will present without these features and with an uncertain diagnosis. Even in the latter, early assessment and invasive management may be beneficial, but this is counterbalanced by significant resource utilization, potential to cause harm and the possibility that any diagnostic or therapeutic gains are offset by a poor neurological outcome. Past consensus on the management of the OHCA patient without ST elevation or cardiogenic shock is being challenged by emerging results from new trials in this field. Further randomized trials are ongoing, and are expected to deliver robust data from over 4,000 patients, allowing us to further refine the optimal management strategy in this challenging cohort. This article describes the benefits and pitfalls of a strategy of immediate coronary angiography in these patients, examines the recently published COACT and TOMAHAWK trials in detail, and describes a framework with which to approach the patient after resuscitated OHCA, based on the available evidence to date.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"15 2","pages":"94-102"},"PeriodicalIF":1.9000,"publicationDate":"2021-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524604/pdf/heart-int-15-94.pdf","citationCount":"0","resultStr":"{\"title\":\"Coronary Revascularization and Out-of-hospital Cardiac Arrest: Past, Present and Future.\",\"authors\":\"Matthew E Li Kam Wa, Kalpa De Silva, Nilesh Pareek, Divaka Perera\",\"doi\":\"10.17925/HI.2021.15.2.94\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cardiologists and the cardiac catheter laboratory have key roles to play in the management of patients after out-of-hospital cardiac arrest (OHCA). Although immediate catheter laboratory activation is the standard of care in cardiogenic shock and ST elevation myocardial infarction, the majority of patients will present without these features and with an uncertain diagnosis. Even in the latter, early assessment and invasive management may be beneficial, but this is counterbalanced by significant resource utilization, potential to cause harm and the possibility that any diagnostic or therapeutic gains are offset by a poor neurological outcome. Past consensus on the management of the OHCA patient without ST elevation or cardiogenic shock is being challenged by emerging results from new trials in this field. Further randomized trials are ongoing, and are expected to deliver robust data from over 4,000 patients, allowing us to further refine the optimal management strategy in this challenging cohort. This article describes the benefits and pitfalls of a strategy of immediate coronary angiography in these patients, examines the recently published COACT and TOMAHAWK trials in detail, and describes a framework with which to approach the patient after resuscitated OHCA, based on the available evidence to date.</p>\",\"PeriodicalId\":12836,\"journal\":{\"name\":\"Heart International\",\"volume\":\"15 2\",\"pages\":\"94-102\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2021-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524604/pdf/heart-int-15-94.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/HI.2021.15.2.94\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/HI.2021.15.2.94","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
心脏病专家和心导管实验室在处理院外心脏骤停(OHCA)患者的过程中发挥着关键作用。虽然立即启动导管实验室是治疗心源性休克和 ST 段抬高型心肌梗死的标准,但大多数患者并不具备这些特征,诊断也不明确。即使对后者而言,早期评估和侵入性治疗也可能是有益的,但与此相抵消的是,大量资源的使用、造成伤害的可能性以及任何诊断或治疗效果都可能被不良的神经系统预后所抵消。对于无 ST 段抬高或心源性休克的 OHCA 患者的管理,过去的共识正受到该领域新试验结果的挑战。更多的随机试验正在进行中,预计将提供来自 4000 多名患者的可靠数据,使我们能够进一步完善这一具有挑战性的群体的最佳管理策略。本文介绍了对这些患者立即进行冠状动脉造影术的益处和误区,详细分析了最近发表的 COACT 和 TOMAHAWK 试验,并根据迄今为止的现有证据,介绍了对 OHCA 复苏后患者的处理框架。
Coronary Revascularization and Out-of-hospital Cardiac Arrest: Past, Present and Future.
Cardiologists and the cardiac catheter laboratory have key roles to play in the management of patients after out-of-hospital cardiac arrest (OHCA). Although immediate catheter laboratory activation is the standard of care in cardiogenic shock and ST elevation myocardial infarction, the majority of patients will present without these features and with an uncertain diagnosis. Even in the latter, early assessment and invasive management may be beneficial, but this is counterbalanced by significant resource utilization, potential to cause harm and the possibility that any diagnostic or therapeutic gains are offset by a poor neurological outcome. Past consensus on the management of the OHCA patient without ST elevation or cardiogenic shock is being challenged by emerging results from new trials in this field. Further randomized trials are ongoing, and are expected to deliver robust data from over 4,000 patients, allowing us to further refine the optimal management strategy in this challenging cohort. This article describes the benefits and pitfalls of a strategy of immediate coronary angiography in these patients, examines the recently published COACT and TOMAHAWK trials in detail, and describes a framework with which to approach the patient after resuscitated OHCA, based on the available evidence to date.